For this purpose, a classical approach was taken, fusing the anti-CD3ε scFv to the N-terminus of the VH domain with a (G4S)3 linker, providing a relatively small distance between CD3-engagement and the surface of the tumour cell upon binding. Here, CD3E is linked to neoplasm.